Every earnings season, I see the same headlines:
"Missed analyst expectations."
"Lackluster guidance."
"Stock crashes after earnings."
And every time, I ask myself one question:
Since when did analysts’ assumptions become more important than actual business performance?
recently reported another solid . Revenue...
Everyone knows NVIDIA. Few ask who connects NVIDIA to the world. That’s where opportunities like emerge quietly powering the AI revolution, one connection at a time. The best investments are often discovered before they become household names.
Why...
The "Magnificent Seven" framework is getting tired — a new lens is more useful. Five large AI CapEx spenders (, , , , and ) and roughly 40 AI supplier stocks that are the direct beneficiaries of that...
The AI boom has triggered an insatiable need for new, localized, decentralized and clean alternative power generation methods. While there has been much speculation about small modular nuclear reactors, regulatory hurdles can delay this possibility for many years....
Merck & Company Inc () has gone from patent-cliff worry to large-cap pharma comeback story.Not long ago, the stock was being valued like a mature drugmaker with one giant problem: Keytruda. Merck’s blockbuster cancer therapy remains one of...
